Literature DB >> 28653164

Should DBS for Psychiatric Disorders be Considered a Form of Psychosurgery? Ethical and Legal Considerations.

Devan Stahl1, Laura Cabrera2, Tyler Gibb3.   

Abstract

Deep brain stimulation (DBS), a surgical procedure involving the implantation of electrodes in the brain, has rekindled the medical community's interest in psychosurgery. Whereas many researchers argue DBS is substantially different from psychosurgery, we argue psychiatric DBS-though a much more precise and refined treatment than its predecessors-is nevertheless a form of psychosurgery, which raises both old and new ethical and legal concerns that have not been given proper attention. Learning from the ethical and regulatory failures of older forms of psychosurgery can help shed light on how to address the regulatory gaps that exist currently in DBS research. To show why it is important to address the current regulatory gaps within psychiatric DBS, we draw on the motivations underlying the regulation of earlier forms of psychosurgery in the US. We begin by providing a brief history of psychosurgery and electrical brain stimulation in the US. Against this backdrop, we introduce psychiatric DBS, exploring current research and ongoing clinical trials. We then draw out the ethical and regulatory similarities between earlier forms of psychosurgery and psychiatric DBS. As we will show, the factors that motivated strict regulation of earlier psychosurgical procedures mirror concerns with psychiatric DBS today. We offer three recommendations for psychiatric DBS regulation, which echo earlier motivations for regulating psychosurgery, along with new considerations that reflect the novel technologies used in DBS.

Entities:  

Keywords:  Deep brain stimulation; Legal regulations; Neuroethics; Psychiatric disorders; Psychosurgery

Mesh:

Year:  2017        PMID: 28653164     DOI: 10.1007/s11948-017-9934-y

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  56 in total

1.  What makes clinical research ethical?

Authors:  E J Emanuel; D Wendler; C Grady
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

2.  Psychosurgery: a historical overview.

Authors:  R P Feldman; J T Goodrich
Journal:  Neurosurgery       Date:  2001-03       Impact factor: 4.654

3.  ELECTRICAL SELF-STIMULATION OF THE BRAIN IN MAN.

Authors:  R G HEATH
Journal:  Am J Psychiatry       Date:  1963-12       Impact factor: 18.112

Review 4.  The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease.

Authors:  Susan H Fox; Regina Katzenschlager; Shen-Yang Lim; Bernard Ravina; Klaus Seppi; Miguel Coelho; Werner Poewe; Olivier Rascol; Christopher G Goetz; Cristina Sampaio
Journal:  Mov Disord       Date:  2011-10       Impact factor: 10.338

5.  Deep brain stimulation: avoiding the errors of psychosurgery.

Authors:  Morten L Kringelbach; Tipu Z Aziz
Journal:  JAMA       Date:  2009-04-22       Impact factor: 56.272

6.  Criteria for the ethical conduct of psychiatric neurosurgery clinical trials.

Authors:  Nir Lipsman; Mark Bernstein; Andres M Lozano
Journal:  Neurosurg Focus       Date:  2010-08       Impact factor: 4.047

7.  Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience.

Authors:  B D Greenberg; L A Gabriels; D A Malone; A R Rezai; G M Friehs; M S Okun; N A Shapira; K D Foote; P R Cosyns; C S Kubu; P F Malloy; S P Salloway; J E Giftakis; M T Rise; A G Machado; K B Baker; P H Stypulkowski; W K Goodman; S A Rasmussen; B J Nuttin
Journal:  Mol Psychiatry       Date:  2008-05-20       Impact factor: 15.992

8.  Origin and evolution of deep brain stimulation.

Authors:  Vittorio A Sironi
Journal:  Front Integr Neurosci       Date:  2011-08-18

9.  Deep Brain Stimulation for Obsessive-Compulsive Disorder: A Meta-Analysis of Treatment Outcome and Predictors of Response.

Authors:  Pino Alonso; Daniel Cuadras; Loes Gabriëls; Damiaan Denys; Wayne Goodman; Ben D Greenberg; Fiacro Jimenez-Ponce; Jens Kuhn; Doris Lenartz; Luc Mallet; Bart Nuttin; Eva Real; Cinto Segalas; Rick Schuurman; Sophie Tezenas du Montcel; Jose M Menchon
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

10.  Consensus on guidelines for stereotactic neurosurgery for psychiatric disorders.

Authors:  Bart Nuttin; Hemmings Wu; Helen Mayberg; Marwan Hariz; Loes Gabriëls; Thorsten Galert; Reinhard Merkel; Cynthia Kubu; Osvaldo Vilela-Filho; Keith Matthews; Takaomi Taira; Andres M Lozano; Gastón Schechtmann; Paresh Doshi; Giovanni Broggi; Jean Régis; Ahmed Alkhani; Bomin Sun; Sam Eljamel; Michael Schulder; Michael Kaplitt; Emad Eskandar; Ali Rezai; Joachim K Krauss; Paulien Hilven; Rick Schuurman; Pedro Ruiz; Jin Woo Chang; Paul Cosyns; Nir Lipsman; Juergen Voges; Rees Cosgrove; Yongjie Li; Thomas Schlaepfer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-01-20       Impact factor: 10.154

View more
  5 in total

1.  Neuroethics of Neuromodulation: An Update.

Authors:  Peter Zuk; Laura Torgerson; Demetrio Sierra-Mercado; Gabriel Lázaro-Muñoz
Journal:  Curr Opin Biomed Eng       Date:  2018-10-26

2.  No going back? Reversibility and why it matters for deep brain stimulation.

Authors:  Jonathan Pugh
Journal:  J Med Ethics       Date:  2019-01-10       Impact factor: 2.903

3.  Deep brain stimulation and revising the Mental Health Act: the case for intervention-specific safeguards.

Authors:  Jonathan Pugh; Tipu Aziz; Jonathan Herring; Julian Savulescu
Journal:  Br J Psychiatry       Date:  2019-03       Impact factor: 9.319

4.  Medical Students' Knowledge and Perception of Deep Brain Stimulation.

Authors:  Brian F Saway; Sanaz Monjazeb; Kerilyn Godbe; Tessa Anwyll; Anita Kablinger; Mark Witcher
Journal:  J Med Educ Curric Dev       Date:  2021-03-02

5.  Deep Brain Stimulation for Obsessive-Compulsive Disorder: Real World Experience Post-FDA-Humanitarian Use Device Approval.

Authors:  Lora Kahn; Brianne Sutton; Helena R Winston; Aviva Abosch; John A Thompson; Rachel A Davis
Journal:  Front Psychiatry       Date:  2021-03-24       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.